Evaluation of a Screening Strategy for Sarcopenia: a Monocentric Prospective Cohort Study (STRAS) — STRAS  

Sarcopenia Clinical Trial

Official title: Evaluation of a Screening Strategy for Sarcopenia: a Monocentric Prospective Cohort Study

Status Terminated

Clinical Trial Summary

The main objective of this study is to determine the prevalence of sarcopenia in patients hospitalized in the follow-up care and rehabilitation units of the geriatrics department of the Mulhouse French hospital.

Clinical Trial Description

Secondary objectives

1. To assess the performance of the SARC-F questionnaire to screen for sarcopenia ;

2. To describe the characteristics of sarcopenic patients hospitalized in each follow-up care and rehabilitation unit (i.e. day hospital, full hospitalization);

3. To identify predictive factors of sarcopenia;

4. To determine, in the subgroup of patients hospitalized in the conventional follow-up care and rehabilitation unit (i.e. full hospitalization), the evolution of sarcopenia between admission and discharge of the following variables :

1. muscle strength,

2. muscle mass,

3. functional ability,

4. dependency.

Conduct of research

After receiving the written consent of the study participant, all of the following tests and questionnaires will be performed :

• SARC-F questionnaire,

• measurement of muscle strengh by a grip test,

• measurement of muscle mass by impedancemetry (ASM/size2),

• 4-meter walking speed test,

• Timed-Up and Go (TUG) test,

• ADL (Activities of Daily Living) and IADL (Instrumental Activities of Daily Living) questionnaires.

For patients in day hospital care, the study will end upon completion of these tests.

For patients hospitalized in the conventional follow-up care and rehabilitation unit (i.e. full hospitalization), a follow-up visit will be scheduled within 72 hours prior to the patient's discharge from the service, or at 3 months of hospitalization. The following tests and questionnaires will be performed during this visit:

• measurement of muscle strengh by a grip test,

• measurement of muscle mass by impedancemetry,

• 4-meter walking speed test,

• Timed Up and Go (TUG) test,

• ADL and IADL questionnaires. ;

Related Conditions & MeSH terms

• Sarcopenia

• NCT number: NCT04827758
• Study type: Interventional
• Source: Groupe Hospitalier de la Region de Mulhouse et Sud Alsace
• Status: Terminated
• Phase: N/A
• Start date: April 22, 2021
• Completion date: September 23, 2022